Patents | Intellepedia

Patentability requirements – A Presentation by Dr. Kalyan C. Kankanala at NLS – Bangalore

[slideshare id=123861782&doc=patentabilityinindia-181124124503]

New patent policy in India? Interesting Patents, L’Oréal vesrus Drunk Elephant, No patent settlement talks for Qualcomm and Apple, No patent for Pfizer’s Pregablin says Supreme Court and more

The post presents a comprehensive overview of recent patent policy changes, key legal disputes, and statistical trends in India. It also covers prominent international IP events and critical judicial decisions impacting the patent landscape.

Interesting Patents, IIT-M to host Tech summit, Cannabis Patent, Qualcomm forced to license its patents, Canada becomes party to Hague Agreement, USPTO’s new Sponsorship Tool and more

This update reviews Indian patent statistics, significant inventions, and key legal news in intellectual property. Highlights include the IIT Madras tech summit, Qualcomm’s licensing directive, cannabis patent developments, and Canada joining the Hague Agreement. The post provides a concise overview of national and international IP updates.

Rejection of Application Based on Pre-Grant Representation May Be Appealed to IPAB

The Delhi High Court has clarified that appeals to the IPAB are permitted when a patent application is rejected based on pre-grant representation. This judgment offers clear recourse for patent applicants and settles the legal position on such appeals under Indian patent law.

What Should I do With My Invention Before I Talk to Venture Capitalists?

The article examines how inventors can protect their inventions before approaching venture capitalists, weighing the effectiveness of NDAs versus patent filings. It highlights the steps for obtaining a patentability opinion, conducting searches, and filing a patent application in India.

Pharmaceutical Business Strategy – A Brand Name Perspective

The post explores how brand name drug companies exploit regulatory provisions to maintain market dominance during generic drug challenges. It details the legal and procedural mechanisms involved, focusing on the strategic use of the 30 month stay period under the Hatch Waxman Act.

Pharmaceutical Business Strategy – A Generics Perspective

This article examines the strategy of generic drug companies in challenging pharmaceutical patents, focusing on Paragraph IV certifications and related litigation. It highlights trends, success rates, and the increasing participation of Indian companies in the US generics market.

Assessing Patent Risks in India

This post examines the essential steps for assessing patent risks in India, focusing on infringement analysis and the tests for equivalence. It also considers the relevance of exemptions and the need for detailed, technology-specific evaluation in patent matters.

Patent Infringement Analysis or FTO Analysis in India – Challenges

The post analyses the unique challenges of patent infringement and FTO analysis in India, particularly due to limited online patent data. It highlights the risks involved and the need for improved Indian Patent Office resources.

Temporary Injunction Cases

This post examines two landmark Indian cases where courts declined temporary injunctions in patent infringement suits. The judgments clarify the principles guiding interim relief, including the need for a prima facie case and a favourable balance of convenience.